Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Lavieri

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Bioethics : AJOB|May 15, 2007
The ethical mouse: be not like IcarusRobert R Lavieri
The American Journal of Bioethics : AJOB|November 7, 2006
Ethical considerations in the communication of unexpected information with clinical implicationsRobert R Lavieri, Samual A Garner
Chemical Reviews|September 23, 2011
Phospholipase D: enzymology, functionality, and chemical modulationPaige E Selvy, Robert R Lavieri, Craig W Lindsley, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 20, 2020
Machine learning on drug-specific data to predict small molecule teratogenicityAnup P Challa, Andrew L Beam, Min Shen, et al.
Nature Medicine|May 28, 2020
EHRs could clarify drug safety in pregnant peopleAnup P Challa, Robert R Lavieri, Ethan S Lippmann, et al.
Assay and Drug Development Technologies|November 27, 2019
Systematically Prioritizing Candidates in Genome-Based Drug RepurposingAnup P Challa, Robert R Lavieri, Judith T Lewis, et al.
Journal of Medicinal Chemistry|August 26, 2010
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorRobert R Lavieri, Sarah A Scott, Paige E Selvy, et al.
Communications Medicine|September 20, 2022
Medication history-wide association studies for pharmacovigilance of pregnant patientsAnup P Challa, Xinnan Niu, Etoi A Garrison, et al.
ACS Chemical Biology|November 11, 2014
Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymesSarah A Scott, Cierra T Spencer, Matthew C O'Reilly, et al.
Annual Review of Pharmacology and Toxicology|July 25, 2019
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M Pulley, Jillian P Rhoads, Rebecca N Jerome, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Bioethics : AJOB|May 15, 2007
The ethical mouse: be not like IcarusRobert R Lavieri
The American Journal of Bioethics : AJOB|November 7, 2006
Ethical considerations in the communication of unexpected information with clinical implicationsRobert R Lavieri, Samual A Garner
Chemical Reviews|September 23, 2011
Phospholipase D: enzymology, functionality, and chemical modulationPaige E Selvy, Robert R Lavieri, Craig W Lindsley, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 20, 2020
Machine learning on drug-specific data to predict small molecule teratogenicityAnup P Challa, Andrew L Beam, Min Shen, et al.
Nature Medicine|May 28, 2020
EHRs could clarify drug safety in pregnant peopleAnup P Challa, Robert R Lavieri, Ethan S Lippmann, et al.
Assay and Drug Development Technologies|November 27, 2019
Systematically Prioritizing Candidates in Genome-Based Drug RepurposingAnup P Challa, Robert R Lavieri, Judith T Lewis, et al.
Journal of Medicinal Chemistry|August 26, 2010
Design, synthesis, and biological evaluation of halogenated N-(2-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: discovery of an isoform-selective small molecule phospholipase D2 inhibitorRobert R Lavieri, Sarah A Scott, Paige E Selvy, et al.
Communications Medicine|September 20, 2022
Medication history-wide association studies for pharmacovigilance of pregnant patientsAnup P Challa, Xinnan Niu, Etoi A Garrison, et al.
ACS Chemical Biology|November 11, 2014
Discovery of desketoraloxifene analogues as inhibitors of mammalian, Pseudomonas aeruginosa, and NAPE phospholipase D enzymesSarah A Scott, Cierra T Spencer, Matthew C O'Reilly, et al.
Annual Review of Pharmacology and Toxicology|July 25, 2019
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics DataJill M Pulley, Jillian P Rhoads, Rebecca N Jerome, et al.
Pageof 2